Breaking News Instant updates and real-time market news.

RH

RH

$241.95

8.72 (3.74%)

07:31
12/09/19
12/09
07:31
12/09/19
07:31

RH price target raised to $275 from $200 at Guggenheim

Guggenheim analyst Steven Forbes raised his price target for RH to $275 from $200 saying 2020 should bring the return of double-digit revenue growth while a launch of RH International could happen in 2021 versus expectations of 2022. The latter is a "meaningful potential catalyst" for both investor sentiment and revenue, Forbes tells investors in a research note. RH in late September set its two most important market share drivers, real estate transformation and product innovation/brand extensions, "back in motion concurrently for the first time in four years," contends the analyst, who reiterates a Buy rating on the shares.

RH RH
$241.95

8.72 (3.74%)

11/21/19
LOOP
11/21/19
DOWNGRADE
Target $190
LOOP
Hold
RH cut to Hold at Loop Capital on valuation
Loop Capital analyst Anthony Chukumba downgraded RH to Hold from Buy with an unchanged price target of $190. The analyst notes that the company is still "one of the most compelling small cap fundamental growth stories" in the specialty hardlines retail sector, but at 14.8-times forward earnings, he sees the upside potential and downside risk as "fairly balanced". Chukumba adds that he remains balanced on RH's differentiated concept, substantial domestic growth runway,, and the prospects for its RH Beach House and RH Ski House source books.
12/05/19
UBSW
12/05/19
NO CHANGE
Target $210
UBSW
Neutral
RH price target raised to $210 from $160 at UBS
UBS analyst Michael Lasser raised his price target on RH to $210 after its Q3 earnings beat and raised guidance for FY19 and long term revenue growth. The analyst still keeps his Neutral rating on the stock however, noting that its implied Q4 guidance indicates a 600bps sequential deceleration on a 2-year stack. Lasser adds that while RH has kept its SG&A costs flat for the 2nd consecutive quarter, it is not realistic to expect its operating expenses to be flat, as the company's "big aspirations" will require investments. The analyst further notes that the gains in RH stock price anticipated Q3 results, which should keep the gains muted.
12/05/19
BARD
12/05/19
NO CHANGE
Target $220
BARD
Outperform
RH price target raised to$220 from $168 at Baird
Baird analyst Peter Benedict raised his price target on RH to $220 from $168 following impressive Q3 results. The analyst noted revenues were inline with expectations but a stronger gross margin and a lower tax rate drove a roughly 25% earnings beat. He remains bullish on the long-term opportunity for the brand but he remains on the sidelines due to lingering cyclical-related risks. Benedict maintained his Neutral rating on RH shares.
12/05/19
STFL
12/05/19
NO CHANGE
Target $230
STFL
Buy
RH price target raised to $230 from $202 at Stifel
Stifel analyst John Baugh said RH reported "strong" Q3 results, including EBIT margins that were "quite strong." He thinks estimates for 2020 will likely see meaningful upward revisions given the guidance for 200 basis points of year-over-year operating margin growth and he raised his price target on RH shares to $230 from $202 to account for his own increased estimates. The analyst, who added that he is confident in the company's ability to forecast margins, keeps a Buy rating on RH shares.

TODAY'S FREE FLY STORIES

EHC

Encompass Health

$79.50

-0.77 (-0.96%)

07:31
01/21/20
01/21
07:31
01/21/20
07:31
Hot Stocks
Encompass Health plans to build rehabilitation hospital in South Carolina »

Encompass Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

WPC

W.P. Carey

$83.13

-0.14 (-0.17%)

07:31
01/21/20
01/21
07:31
01/21/20
07:31
Hot Stocks
W.P. Carey announces $112M investment in U.K. Class-A logistics facility »

W. P. Carey announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INGR

Ingredion

$92.58

-0.355 (-0.38%)

, FISV

Fiserv

$120.69

0.46 (0.38%)

07:30
01/21/20
01/21
07:30
01/21/20
07:30
Hot Stocks
Ingredion appoints Tiffany Willis as VP, investor relations »

Ingredion (INGR)…

INGR

Ingredion

$92.58

-0.355 (-0.38%)

FISV

Fiserv

$120.69

0.46 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Feb

  • 17

    Feb

TSLA

Tesla

$510.34

-3.065 (-0.60%)

07:29
01/21/20
01/21
07:29
01/21/20
07:29
Recommendations
Tesla analyst commentary  »

Tesla near-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 24

    Feb

  • 23

    Mar

  • 23

    Mar

ORGS

Orgenesis

$5.40

0.36 (7.14%)

07:28
01/21/20
01/21
07:28
01/21/20
07:28
Hot Stocks
Orgenesis announces $9.2M private placement »

Orgenesis announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LAC

Lithium Americas

$4.12

-0.05 (-1.20%)

07:27
01/21/20
01/21
07:27
01/21/20
07:27
Hot Stocks
Lithium Americas receives notice of intent for Thacker Pass lithium project »

Lithium Americas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 12

    Mar

EQT

EQT Corporation

$8.25

-0.28 (-3.28%)

07:27
01/21/20
01/21
07:27
01/21/20
07:27
Upgrade
EQT Corporation rating change  »

EQT Corporation upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VERU

Veru

$4.19

0.07 (1.70%)

07:25
01/21/20
01/21
07:25
01/21/20
07:25
Recommendations
Veru analyst commentary  »

Veru price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUAN

Nuance

$19.74

-0.02 (-0.10%)

07:24
01/21/20
01/21
07:24
01/21/20
07:24
Hot Stocks
Nuance announces Dragon Medical One availability in France, Belgium, Netherlands »

Nuance Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 05

    Feb

MRSN

Mersana Therapeutics

$8.05

0.42 (5.50%)

07:23
01/21/20
01/21
07:23
01/21/20
07:23
Recommendations
Mersana Therapeutics analyst commentary  »

Mersana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EOG

EOG Resources

$85.35

-1.66 (-1.91%)

07:22
01/21/20
01/21
07:22
01/21/20
07:22
Upgrade
EOG Resources rating change  »

EOG Resources upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

KMDA

Kamada

$6.62

0.09 (1.38%)

07:21
01/21/20
01/21
07:21
01/21/20
07:21
Hot Stocks
Kamada announces $25M private placement with FIMI Opportunity Fund »

Kamada announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LTHM

Livent

$8.90

0.05 (0.57%)

07:21
01/21/20
01/21
07:21
01/21/20
07:21
Downgrade
Livent rating change  »

Livent downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KVHI

KVH Industries

$10.91

0.05 (0.46%)

, LMT

Lockheed Martin

$425.62

-0.055 (-0.01%)

07:20
01/21/20
01/21
07:20
01/21/20
07:20
Hot Stocks
Lockheed Martin selects KVH fiber optic gyro for infrared search, track system »

KVH Industries (KVHI)…

KVHI

KVH Industries

$10.91

0.05 (0.46%)

LMT

Lockheed Martin

$425.62

-0.055 (-0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

BIDU

Baidu

$139.64

0.2 (0.14%)

07:18
01/21/20
01/21
07:18
01/21/20
07:18
Recommendations
Baidu analyst commentary  »

Baidu price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

DIS

Disney

$144.25

-0.85 (-0.59%)

07:18
01/21/20
01/21
07:18
01/21/20
07:18
Hot Stocks
Disney+ moves up EMEA launch date to March 24 »

Disney's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Feb

RDHL

RedHill Biopharma

$6.16

0.11 (1.82%)

07:18
01/21/20
01/21
07:18
01/21/20
07:18
Hot Stocks
RedHill Biopharma discontinues promotion of Donnatal, EnteraGam »

RedHill Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSU

Kansas City Southern

$166.57

4.77 (2.95%)

07:17
01/21/20
01/21
07:17
01/21/20
07:17
Initiation
Kansas City Southern initiated  »

Benchmark starts Kansas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGNE

BeiGene

$170.73

2.85 (1.70%)

07:16
01/21/20
01/21
07:16
01/21/20
07:16
Hot Stocks
BeiGene says Phase 3 trial of tislelizumab meets primary endpoint »

BeiGene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

CSX

CSX

$76.36

-0.39 (-0.51%)

07:16
01/21/20
01/21
07:16
01/21/20
07:16
Initiation
CSX initiated  »

Benchmark doesn't…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PDD

Pinduoduo

$39.43

-0.07 (-0.18%)

07:15
01/21/20
01/21
07:15
01/21/20
07:15
Recommendations
Pinduoduo analyst commentary  »

Pinduoduo price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MA

MasterCard

$323.60

3.36 (1.05%)

07:15
01/21/20
01/21
07:15
01/21/20
07:15
Initiation
MasterCard initiated  »

MasterCard initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

V

Visa

$204.71

3.765 (1.87%)

07:14
01/21/20
01/21
07:14
01/21/20
07:14
Initiation
Visa initiated  »

Visa initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 30

    Jan

  • 11

    Feb

ETON

Eton Pharmaceuticals

$7.14

-0.3 (-4.03%)

07:14
01/21/20
01/21
07:14
01/21/20
07:14
Hot Stocks
Eton Pharmaceuticals, Xellia announce Biorphen co-promotion agreement »

Eton Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Mar

MYGN

Myriad Genetics

$28.71

-0.21 (-0.73%)

, AZN

AstraZeneca

$51.34

0.84 (1.66%)

07:13
01/21/20
01/21
07:13
01/21/20
07:13
Hot Stocks
Myriad Genetics submits sPMA for BRACAnalysis CDx as companion diagnostic »

Myriad Genetics (MYGN)…

MYGN

Myriad Genetics

$28.71

-0.21 (-0.73%)

AZN

AstraZeneca

$51.34

0.84 (1.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 06

    Feb

  • 13

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.